Stay updated on Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial

Sign up to get notified when there's something new on the Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T21:47:41.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the safety evaluation of ZX008 (fenfluramine) in patients with Dravet syndrome or Lennox Gastaut syndrome who are taking cannabidiol (CBD). This change may reflect new information or findings in the ongoing study regarding the safety and tolerability of the medication combination.
    Difference
    0.2%
    Check dated 2024-06-06T14:25:56.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying the health conditions and prior treatments required for inclusion in the study. Previously, no information was provided in this section.
    Difference
    20%
    Check dated 2024-05-22T20:33:22.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:26:22.000Z thumbnail image

Stay in the know with updates to Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial page.